SCHEMBL868337

SCHEMBL868337

[Nb].[Tc]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7736801 0.82
SCHEMBL7736803 0.82
SCHEMBL29375646 0.71
SCHEMBL9175196 0.71
SCHEMBL29872243 0.71
SCHEMBL29494657 0.71
SCHEMBL6587 0.71
SCHEMBL25902 0.71
SCHEMBL11034701 0.71
SCHEMBL29767319 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120076704-A1 CATALYSTS, SYSTEM AND METHOD FOR HYDROGEN PRODUCTION CHART, INC. (US) 2012-03-29 US claimed
US-20090257928-A1 Catalysts, system and method for hydrogen production U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS THE NOTES COLLATERAL AGENT 2009-10-15 US claimed
US-20210138066-A1 REMOTE-CONTROLLED IMAGE-GUIDED DRUG DELIVERY VIA ULTRASOUND-MODULATED MOLECULAR DIFFUSION CALIFORNIA INSTITUTE OF TECHNOLOGY 2021-05-13 US disclosed
US-20200297854-A1 NANOTHERAPEUTICS FOR DRUG TARGETING PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-09-24 US disclosed
US-20150147276-A1 NANOTHERAPEUTICS FOR DRUG TARGETING PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-05-28 US disclosed
EP-2858630-A1 NANOTHERAPEUTICS FOR DRUG TARGETING President and Fellows of Harvard College (US) 2015-04-15 EP disclosed
WO-2013185032-A1 NANOTHERAPEUTICS FOR DRUG TARGETING PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-12-12 WO disclosed